Download Free Sample
Buy Now
Table of Contents
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
3.1. Chapter Overview
3.2. Overview of Polymers
3.2.1. Historical Development of Polymers
3.2.2. Properties of Polymers
3.2.2.1. Physical Properties
3.2.2.2. Chemical Properties
3.2.2.3. Mechanical Properties
3.2.3. Classification of Polymers
3.2.3.1. Classification based on Molecular Forces
3.2.3.2. Classification based on Origin of Source
3.2.3.3. Classification based on Structure of Molecular Chain
3.2.3.4. Classification based on Monomers
3.2.3.5. Classification based on Backbone Chain
3.2.3.6. Classification based on Degradation Capability
3.2.3.7. Classification based on Morphology
3.2.4. Applications of Polymers in Pharmaceutical / Medical Domain
3.2.4.1. Pharmaceutical Formulation
3.2.4.2. Drug Delivery System
3.2.4.3. Gene Therapy
3.2.4.4. Stability Enhancer
3.2.4.5. Vaccine Adjuvant
3.2.4.6. Tissue Engineering
3.2.4.7. Dentistry
3.2.4.8. Packaging
3.2.4.9. Medical Device Coating
3.2.4.10. Others
3.3. Concluding Remarks
4.1. Chapter Overview
4.2. Pharmaceutical Polymer / Medical Polymer Manufacturers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Company Size and Location of Headquarters
4.2.5. Analysis by Source of Polymer
4.2.6. Analysis by Composition of Polymer
4.2.7. Analysis by Type of Polymer
4.2.8. Analysis by Area of Application
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Pharmaceutical Polymer / Medical Polymer Manufacturers: Company Competitiveness Analysis
5.4.1. Company Competitiveness Analysis: Players based in North America
5.4.2. Company Competitiveness Analysis: Players based in Europe
5.4.3. Company Competitiveness Analysis: Players based in Asia Pacific and Rest of the World
6. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN NORTH AMERICA
6.1. Chapter Overview
6.2. Americhem
6.2.1. Company Overview
6.2.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.2.3. Recent Developments and Future Outlook
6.3. Celanese
6.3.1. Company Overview
6.3.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.3.3. Recent Developments and Future Outlook
6.4. Eastman
6.4.1. Company Overview
6.4.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.4.3. Recent Developments and Future Outlook
6.5. Lubrizol Life Science
6.5.1. Company Overview
6.5.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.5.3. Recent Developments and Future Outlook
6.6. LyondellBasell
6.6.1. Company Overview
6.6.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
6.6.3. Recent Developments and Future Outlook
7. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN EUROPE
7.1. Chapter Overview
7.2. Borealis
7.2.1. Company Overview
7.2.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.2.3. Recent Developments and Future Outlook
7.3. Henkel
7.3.1. Company Overview
7.3.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.3.3. Recent Developments and Future Outlook
7.4. KRAIBURG TPE
7.4.1. Company Overview
7.4.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.4.3. Recent Developments and Future Outlook
7.5. SEQENS
7.5.1. Company Overview
7.5.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.5.3. Recent Developments and Future Outlook
7.6. Solvay
7.6.1. Company Overview
7.6.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
7.6.3. Recent Developments and Future Outlook
8. COMPANY PROFILES: PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS IN ASIA-PACIFIC AND REST OF THE WORLD
8.1. Chapter Overview
8.2. Corel Pharma Chem
8.2.1. Company Overview
8.2.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.2.3. Recent Developments and Future Outlook
8.3. Kuraray
8.3.1. Company Overview
8.3.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.3.3. Recent Developments and Future Outlook
8.4. Phon Tech
8.4.1. Company Overview
8.4.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.4.3. Recent Developments and Future Outlook
8.5. Sumitomo Chemical
8.5.1. Company Overview
8.5.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.5.3. Recent Developments and Future Outlook
8.6. Zylog ElastoComp
8.6.1. Company Overview
8.6.2. Pharmaceutical Polymers / Medical Polymers Focused Portfolio
8.6.3. Recent Developments and Future Outlook
9.1. Chapter Overview
9.2. Partnership Models
9.3. Pharmaceutical Polymers / Medical Polymers: List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Composition of Polymer
9.3.5. Analysis by Type of Polymer
9.3.6. Analysis by Type of Partnership and Type of Polymer
9.3.7. Analysis by Area of Application
9.3.8. Analysis by Type of Partner
9.3.9. Most Active Players: Analysis by Number of Partnerships
9.3.10. Analysis by Geography
9.3.10.1. Intracontinental and Intercontinental Deals
9.3.10.2. International and Local Deals
10. PHARMACEUTICAL POLYMER / MEDICAL POLYMER MANUFACTURERS: DELT ANALYSIS
10.1. Chapter Overview
10.2. Methodology
10.3. Key Parameters
10.3.1. Demographical Factors
10.3.2. Environmental Factors
10.3.3. Legal Factors
10.3.4. Technological Factors
10.4. DELT Analysis: Pharmaceutical Polymer / Medical Polymer Manufacturers
10.4.1. Arkema
10.4.2. Boron Molecular
10.4.3. Celanese
10.4.4. Chempilots
10.4.5. DSM
10.4.6. Evonik
10.4.7. Foryou Medical
10.4.8. JenKem Technology
10.4.9. Kraton
10.4.10. Kuraray
10.4.11. PolyVation
10.4.12. Polyzen
10.4.13. Zylog ElastoComp
10.5. Concluding Remarks
11. CASE STUDY: RECENT TRENDS RELATED TO PHARMACEUTICAL / MEDICAL POLYMERS
11.1. Chapter Overview
11.2. Recent Trends Related to Pharmaceutical / Medical Polymers
11.2.1. Development of Novel Pharmaceutical / Medical Polymers
11.2.1.1. Biodegradable Polymers
11.2.1.2. Smart Polymers
11.2.2. Recycling of Pharmaceutical / Medical Polymers
11.3. Concluding Remarks
12.1. Chapter Overview
12.2. Key Assumptions and Forecast Methodology
12.3. Pharmaceutical Polymers / Medical Polymers Market, 2023-2035
12.3.1. Pharmaceutical Polymers / Medical Polymers Market: Analysis by Type of Polymer, 2023 and 2035
12.3.1.1. Pharmaceutical Polymers / Medical Polymers Market for Thermoplastic Polymers, 2023-2035
12.3.1.2. Pharmaceutical Polymers / Medical Polymers Market for Elastomers, 2023-2035
12.3.1.3. Pharmaceutical Polymers / Medical Polymers Market for Thermoset Polymers, 2023-2035
12.3.1.4. Pharmaceutical Polymers / Medical Polymers Market for Others, 2023-2035
12.3.2. Pharmaceutical Polymers / Medical Polymers Market: Analysis by Area of Application, 2023 and 2035
12.3.2.1. Pharmaceutical Polymers / Medical Polymers Market for Medical Devices, 2023-2035
12.3.2.2. Pharmaceutical Polymers / Medical Polymers Market for Excipients, 2023-2035
12.3.2.3. Pharmaceutical Polymers / Medical Polymers Market for Packaging, 2023-2035
12.3.2.4. Pharmaceutical Polymers / Medical Polymers Market for Others, 2023-2035
12.3.3. Pharmaceutical Polymers / Medical Polymers Market: Analysis by Geography, 2023 and 2035
12.3.3.1. Pharmaceutical Polymers / Medical Polymers Market in North America, 2023-2035
12.3.3.2. Pharmaceutical Polymers / Medical Polymers Market in Europe, 2023-2035
12.3.3.3. Pharmaceutical Polymers / Medical Polymers Market in Asia-Pacific, 2023-2035
12.3.3.4. Pharmaceutical Polymers / Medical Polymers Market in Latin America, 2023-2035
12.3.3.5. Pharmaceutical Polymers / Medical Polymers Market in Middle East and North Africa, 2023-2035
14.1. Chapter Overview
14.2. Cassion Biotech
14.2.1. Company Snapshot
14.2.2. Interview Transcript
14.3. Celares
14.3.1. Company Snapshot
14.3.2. Interview Transcript
14.4. Daikyo Seiko
14.4.1. Company Snapshot
14.4.2. Interview Transcript
Figure 2.1 Executive Summary: Overall Market Landscape
Figure 2.2 Executive Summary: Partnerships and Collaborations
Figure 2.3 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Formation of Polymers
Figure 3.2 Historical Development of Polymers
Figure 3.3 Classification of Polymers
Figure 3.4 Applications of Polymers in Pharmaceutical Domain
Figure 4.1 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Year of Establishment
Figure 4.2 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Company Size
Figure 4.3 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Location of Headquarters (Region-wise)
Figure 4.4 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Location of Headquarters (Country-wise)
Figure 4.5 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Company Size and Location of Headquarters
Figure 4.6 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Source of Polymer
Figure 4.7 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Composition of Polymer
Figure 4.8 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Number of Compositions of Polymer
Figure 4.9 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Type of Polymer
Figure 4.10 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Area of Application
Figure 5.1 Company Competitiveness Analysis: Players based in North America
Figure 5.2 Company Competitiveness Analysis: Players based in Europe
Figure 5.3 Company Competitiveness Analysis: Players based in Asia Pacific and Rest of the world
Figure 9.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2019-2022
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 9.4 Partnerships and Collaborations: Distribution by Composition of Polymer
Figure 9.5 Partnerships and Collaborations: Distribution by Type of Polymer
Figure 9.6 Partnerships and Collaborations: Distribution by Area of Application
Figure 9.7 Partnerships and Collaborations: Distribution by Type of Partner
Figure 9.8 Most Active Players: Distribution by Number of Partnerships
Figure 9.9 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Figure 9.10 Partnerships and Collaborations: Local and International Agreements
Figure 10.1 DELT Analysis: Impact of Internal and External Factors
Figure 10.2 DELT Analysis: Key Parameters
Figure 10.3 DELT Analysis: Arkema
Figure 10.4 DELT Analysis: Boron Molecular
Figure 10.5 DELT Analysis: Celanese
Figure 10.6 DELT Analysis: Chempilots
Figure 10.7 DELT Analysis: DSM
Figure 10.8 DELT Analysis: Evonik
Figure 10.9 DELT Analysis: Foryou Medical
Figure 10.10 DELT Analysis: JenKem Technology
Figure 10.11 DELT Analysis: Kraton
Figure 10.12 DELT Analysis: Kuraray
Figure 10.13 DELT Analysis: PolyVation
Figure 10.14 DELT Analysis: Polyzen
Figure 10.15 DELT Analysis: Zylog ElastoComp
Figure 10.16 DELT Analysis: Concluding Remarks
Figure 11.1 Types of Smart Polymers
Figure 12.1 Global Pharmaceutical Polymers / Medical Polymers Market, 2023-2035 (USD Billion)
Figure 12.2 Pharmaceutical Polymers / Medical Polymers Market, 2023 and 2035: Distribution by Type of Polymer
Figure 12.3 Pharmaceutical Polymers / Medical Polymers Market for Thermoplastic Polymers, 2023-2035 (USD Billion)
Figure 12.4 Pharmaceutical Polymers / Medical Polymers Market for Elastomers, 2023-2035 (USD Billion)
Figure 12.5 Pharmaceutical Polymers / Medical Polymers Market for Thermoset Polymers, 2023-2035 (USD Billion)
Figure 12.6 Pharmaceutical Polymers / Medical Polymers Market for Others, 2023-2035 (USD Billion)
Figure 12.7 Pharmaceutical Polymers / Medical Polymers Market, 2023 and 2035: Distribution by Area of Application
Figure 12.8 Pharmaceutical Polymers / Medical Polymers Market for Medical Devices, 2023-2035 (USD Billion)
Figure 12.9 Pharmaceutical Polymers / Medical Polymers Market for Excipients, 2023-2035 (USD Billion)
Figure 12.10 Pharmaceutical Polymers / Medical Polymers Market for Packaging, 2023-2035 (USD Billion)
Figure 12.11 Pharmaceutical Polymers / Medical Polymers Market for Others, 2023-2035 (USD Billion)
Figure 12.12 Pharmaceutical Polymers / Medical Polymers Market, Distribution by Geography, 2023 and 2035
Figure 12.13 Pharmaceutical Polymers / Medical Polymers Market in North America, 2023-2035 (USD Billion)
Figure 12.14 Pharmaceutical Polymers / Medical Polymers Market in Europe, 2023-2035 (USD Billion)
Figure 12.15 Pharmaceutical Polymers / Medical Polymers Market in Asia Pacific, 2023-2035 (USD Billion)
Figure 12.16 Pharmaceutical Polymers / Medical Polymers Market in Latin America, 2023-2035 (USD Billion)
Figure 12.17 Pharmaceutical Polymers / Medical Polymers Market in Middle East and North Africa, 2023-2035 (USD Billion)
Figure 13.1 Concluding Remarks: Overall Market Landscape
Figure 13.2 Concluding Remarks: Company Competitiveness Analysis
Figure 13.3 Concluding Remarks: Partnership and Collaborations
Figure 13.4 Concluding Remarks: Market Forecast and Opportunity Analysis
Table 4.1 Pharmaceutical Polymers / Medical Polymers: List of Manufacturers
Table 4.2 Pharmaceutical Polymer / Medical Polymer Manufacturers: Information on Type of Polymer, Method of Processing, Method of Sterilization and Area of Application
Table 4.3 Pharmaceutical Polymer / Medical Polymers Manufacturers: Information on Area of Application
Table 6.1 Leading Pharmaceutical Polymer / Medical Polymers Manufacturers based in North America
Table 6.2 Americhem: Company Snapshot
Table 6.3 Americhem: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 6.4 Americhem: Recent Developments and Future Outlook
Table 6.5 Celanese: Company Snapshot
Table 6.6 Celanese: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 6.7 Celanese: Recent Developments and Future Outlook
Table 6.8 Eastman: Company Snapshot
Table 6.9 Eastman: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 6.10 Eastman: Recent Developments and Future Outlook
Table 6.11 Lubrizol Life Science: Company Snapshot
Table 6.12 Lubrizol Life Science: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 6.13 Lubrizol Life Science: Recent Developments and Future Outlook
Table 6.14 LyondellBasell: Company Snapshot
Table 6.15 LyondellBasell: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 6.16 LyondellBasell: Recent Developments and Future Outlook
Table 7.1 Leading Pharmaceutical Polymer / Medical Polymers Manufacturers based in Europe
Table 7.2 Borealis: Company Snapshot
Table 7.3 Borealis: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 7.4 Borealis: Recent Developments and Future Outlook
Table 7.5 Henkel: Company Snapshot
Table 7.6 Henkel: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 7.7 Henkel: Recent Developments and Future Outlook
Table 7.8 KRAIBURG TPE: Company Snapshot
Table 7.9 KRAIBURG TPE: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 7.10 KRAIBURG TPE: Recent Developments and Future Outlook
Table 7.11 SEQENS: Company Snapshot
Table 7.12 SEQENS: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 7.13 SEQENS: Recent Developments and Future Outlook
Table 7.14 Solvay: Company Snapshot
Table 7.15 Solvay: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 7.16 Solvay: Recent Developments and Future Outlook
Table 8.1 Leading Pharmaceutical Polymer / Medical Polymers Manufacturers based in Asia-Pacific
Table 8.2 Corel Pharma Chem: Company Snapshot
Table 8.3 Corel Pharma Chem: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 8.4 Kuraray: Company Snapshot
Table 8.5 Kuraray: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 8.6 Phon Tech: Company Snapshot
Table 8.7 Phon Tech: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 8.8 Sumitomo Chemical: Company Snapshot
Table 8.9 Sumitomo Chemical: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 8.10 Zylog ElastoComp: Company Snapshot
Table 8.11 Zylog ElastoComp: Pharmaceutical Polymers / Medical Polymers Focused Portfolio
Table 9.1 Pharmaceutical Polymers / Medical Polymers: List of Partnerships and Collaborations, 2019-2022
Table 10.1 DELT Analysis: Impact of Internal and External Factors on Leading Players
Table 11.1 Pharmaceutical Polymers / Medical Polymers: List of Biodegradable Polymers
Table 14.1 Caisson Biotech: Company Snapshot
Table 14.2 Celares: Company Snapshot
Table 14.3 Daikyo Seiko: Company Snapshot
Table 15.1 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Year of Establishment
Table 15.2 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Company Size
Table 15.3 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Location of Headquarters (Region-wise)
Table 15.4 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Location of Headquarters (Country-wise)
Table 15.5 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Company Size and Location of Headquarters
Table 15.6 Pharmaceutical Polymer / Medical Polymers Market: Distribution by Source of Polymer
Table 15.7 Pharmaceutical Polymer / Medical Polymers Market: Distribution by Composition of Polymer
Table 15.8 Pharmaceutical Polymer / Medical Polymers Market: Distribution by Number of Composition of Polymer
Table 15.9 Pharmaceutical Polymer / Medical Polymers Market: Distribution by Type of Polymer
Table 15.10 Pharmaceutical Polymer / Medical Polymer Manufacturers: Distribution by Area of Application
Table 15.11 Partnerships and Collaborations: Cumulative Year-wise Trend, 2019-2022
Table 15.12 Partnerships and Collaborations: Distribution by Type of Partnership
Table 15.13 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 15.14 Partnerships and Collaborations: Distribution by Composition of Polymer
Table 15.15 Partnerships and Collaborations: Distribution by Type of Polymer
Table 15.16 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Polymer
Table 15.17 Partnerships and Collaborations: Distribution by Area of Application
Table 15.18 Partnerships and Collaborations: Distribution by Type of Partner
Table 15.19 Most Active Players: Distribution by Number of Partnerships
Table 15.20 Partnerships and Collaborations: Intercontinental and Intracontinental Agreements
Table 15.21 Partnerships and Collaborations: International and Local Agreements
Table 15.22 Global Pharmaceutical Polymers / Medical Polymers Market: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.23 Pharmaceutical Polymers / Medical Polymers Market: Distribution by Type of Polymer, 2023-2035
Table 15.24 Pharmaceutical Polymers / Medical Polymers Market for Thermoplastic Polymers: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.25 Pharmaceutical Polymers / Medical Polymers Market for Elastomers: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.26 Pharmaceutical Polymers / Medical Polymers Market for Thermoset Polymers: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.27 Pharmaceutical Polymers / Medical Polymers Market for Others: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.28 Pharmaceutical Polymers / Medical Polymers Market: Distribution by Area of Application, 2023-2035
Table 15.29 Pharmaceutical Polymers / Medical Polymers Market for Medical Devices: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.30 Pharmaceutical Polymers / Medical Polymers Market for Excipients: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.31 Pharmaceutical Polymers / Medical Polymers Market for Packaging: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.32 Pharmaceutical Polymers / Medical Polymers Market for Others: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.33 Pharmaceutical Polymers / Medical Polymers Market: Distribution by Geography, 2023-2035
Table 15.34 Pharmaceutical Polymers / Medical Polymers Market in North America: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.35 Pharmaceutical Polymers / Medical Polymers Market in Europe: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.36 Pharmaceutical Polymers / Medical Polymers Market in Asia Pacific: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.37 Pharmaceutical Polymers / Medical Polymers Market in Latin America: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Table 15.38 Pharmaceutical Polymers / Medical Polymers Market in Middle East and North Africa: Conservative, Base and Optimistic Scenarios, 2023-2035 (USD Billion)
Please reach out to our team for more details.